BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240108
DTEND;VALUE=DATE:20240111
DTSTAMP:20240106T224238Z
CREATED:20231206T221746Z
LAST-MODIFIED:20240106T224238Z
UID:59580-1704672000-1704931199@globalbiodefense.com
SUMMARY:Biotech Showcase 2024
DESCRIPTION:The Biotech Showcase 2024 investor conference for innovators will be held 8-10 January 2024 in San Francisco and 16-17 January for virtual participants \nThis premier investor conference is a platform for private and micro-mid-cap biotechnology companies\, offering a unique opportunity to showcase innovations and engage one-to-one with investors and biopharmaceutical executives. \nIn attendance at Biotech Showcase\, you’ll find not only executives from biopharmaceutical and life science companies but also private and public company presentations\, investors\, sector analysts\, bankers and industry professionals. \nThrough its specialized showcases—DigiMed Showcase and Seed Showcase—the event also provides convenient access to the life science ecosystem. \nBiotech Showcase is a co-produced by Demy-Colton and EBD Group\, two organizations with a combined experience of over 50 years in producing high-quality programs that foster growth in the biotechnology sector and broader life science industry. \nPlease visit the Biotech Showcase 2024 website for more information.
URL:https://globalbiodefense.com/event/biotech-showcase-2024/
LOCATION:Hilton San Francisco Union Square\, 333 O'Farrell St\, San Francisco\, CA\, 94102\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240115
DTEND;VALUE=DATE:20240120
DTSTAMP:20240111T192843Z
CREATED:20240111T192843Z
LAST-MODIFIED:20240111T192843Z
UID:59610-1705276800-1705708799@globalbiodefense.com
SUMMARY:World Economic Forum Annual Meeting
DESCRIPTION:The 54th Annual Meeting of the World Economic Forum will be held 15-19 January 2024 in Davos-Klosters\, Switzerland. The meeting is accessible to the wider public through the livestreaming of over 200 sessions. \nThis Annual Meeting will welcome over 100 governments\, all major international organizations\, 1000 Forum’s Partners\, as well as civil society leaders\, experts\, youth representatives\, social entrepreneurs\, and news outlets. \nThe meeting convenes under the theme Rebuilding Trust\, accessible to the wider public with over 200 sessions livestreamed – the full programme is available here. \nHighlighted agenda sessions include: \n\nFacing a World Without Antibiotics\nWhen Climate Impacts Your Health\nSupply Chains of the Future\nClimate and Nature: Seed Capital Needed\nProtecting the Vulnerable Online\nSpecial Address by Volodymyr Zelenskyy\, President of Ukraine\nGenerative AI: Steam Engine of the Fourth Industrial Revolution?\n\n\nLast year at Davos\, the word ‘polycrisis‘ was on everybody’s lips as leaders deliberated the cascading and connected crises of the moment. Today\, even as we turn our attention to new crises\, the old ones persist. \n\n\n“At a time when global challenges require urgent solutions\, innovative public-private collaboration is necessary to convert ideas into action. The Forum provides the structure for developing research\, alliances and frameworks that promote mission-driven cooperation throughout the year\,” said Børge Brende\, President\, World Economic Forum. \nMore than 300 public figures will participate this year\, including more than 60 heads of state and government. There will be strong representation from all key regions of the world. \n\nAn estimated 1\,600 business leaders\, including 800-plus of the world’s top CEOs and chairs from the World Economic Forum’s Members and Partners\, will participate. There will also be more than 150 Global Innovators\, Tech Pioneers and Unicorns who are transforming industries. \n\n\nMore than 200 members of the Forum’s Global Shapers\, Young Global Leaders and Social Entrepreneurs communities will join to showcase local innovations and solutions. Also taking part in the meeting will be more than 150 experts and heads of the world’s leading universities\, research institutions and think tanks. More than 40 labour\, nongovernment organization and religious leaders from civil society will take part as well. \n\n\nHeads of civil society organizations include: Kirsten Schuijt\, Director-General\, WWF International; David Miliband\, President\, International Rescue Committee; Luc Triangle\, General Secretary\, International Trade Union Confederation; Tirana Hassan\, Executive Director\, Human Rights Watch. \n\n\nPlease visit the World Economic Forum 2024 Annual Meeting website for more information.
URL:https://globalbiodefense.com/event/world-economic-forum-annual-meeting/
LOCATION:https://www.weforum.org/events/world-economic-forum-annual-meeting-2024/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240122
DTEND;VALUE=DATE:20240128
DTSTAMP:20240111T173857Z
CREATED:20240111T173650Z
LAST-MODIFIED:20240111T173857Z
UID:59597-1705881600-1706399999@globalbiodefense.com
SUMMARY:WHO Executive Board Meeting
DESCRIPTION:The World Health Organization will convene the 154th session of the WHO Executive Board in Geneva from 22-27 January 2024. \nThe Executive Board is composed of 34 technically qualified members elected for three-year terms. The annual Board meeting is held in January when the members agree upon the agenda for the World Health Assembly (scheduled for May 2024) and the resolutions to be considered by the Health Assembly\, including the 2025-2028 Programme of Work\, sustainable financing\, and global health emergency priorities and processes. \nHighlighted agenda items (links below) include the Draft Global Action Plan for Infection Prevention and Control; Immunization Agenda; Antimicrobial resistance operational priorities 2025-2035; Smallpox eradication: destruction of variola virus stocks; Public health emergencies: preparedness and response; Strengthening the global architecture for health emergency preparedness\, prevention and response and resilience. \nProceedings will be webcast and recorded for on-demand viewing. \n\nThe Executive Board\n\n\n\nChair and Officers of the Executive Board \nComposition of the Executive Board \nEB154/1\nProvisional agenda \nEB154/1 (annotated)\nProvisional agenda (annotated) \nEB154/3\nReport of the regional committees to the Executive Board \nEB154/5\nReport of the Standing Committee on Health Emergency Prevention\, Preparedness and Response \nEB154/6\nUniversal health coverage \nEB154/7\nFollow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases\nPrevention and management of noncommunicable diseases\, promotion of mental health and well-being\, and treatment and care of mental health conditions \nEB154/8\nDraft global action plan for infection prevention and control\nDraft global action plan and monitoring framework \nEB154/8 Add.1\nDraft global action plan on infection prevention and control\nDraft global action plan and monitoring framework: minimum requirements for IPC programmes at national and health care facility levels \nEB154/9\nImmunization Agenda 2030\nProgress towards global immunization goals and implementation of the Immunization Agenda 2030 \nEB154/10\nEnd TB Strategy\nProgress in implementing the global strategy and targets for tuberculosis prevention\, care and control after 2015 (the End TB Strategy) \nEB154/11\nRoad map for neglected tropical diseases 2021–2030 \nEB154/12\nAcceleration towards the Sustainable Development Goal targets for maternal health and child mortality \nEB154/13\nAntimicrobial resistance: accelerating national and global responses\nWHO strategic and operational priorities to address drug-resistant bacterial infections in the human health sector\, 2025–2035 \nEB154/14\nWHO’s work in health emergencies\nPublic health emergencies: preparedness and response \nEB154/15\nWHO’s work in health emergencies\nStrengthening the global architecture for health emergency preparedness\, prevention and response and resilience \nEB154/16\nImplementation of resolution WHA75.11 (2022) \nEB154/17\nGlobal Health and Peace Initiative \nEB154/18\nPoliomyelitis\nPoliomyelitis eradication \nEB154/19\nPoliomyelitis\nPolio transition planning and polio post-certification \nEB154/20\nSmallpox eradication: destruction of variola virus stocks \nEB154/21\nSocial determinants of health\nProgress of the World Report on Social Determinants of Health Equity \nEB154/23\nWell-being and health promotion \nEB154/24\nClimate change\, pollution and health\nImpact of chemicals\, waste and pollution on human health \nEB154/25\nClimate change and health \nEB154/27\nFinancing and implementation of the Programme budget 2022–2023 and outlook on financing of the Programme budget 2024–2025 \nEB154/28\nDraft fourteenth general programme of work \nEB154/29 Rev.1\nSustainable financing: WHO investment round \nEB154/32\nMatters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary\, Programmatic and Financing Governance\nSecretariat implementation plan on reform \nEB154/33\nMatters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary\, Programmatic and Financing Governance\nStrengthening WHO’s budgetary\, programmatic and financing governance: follow-up to the implementation of decision EB152(15) (2023) \nEB154/33 Add.1\nMatters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary\, Programmatic and Financing Governance\nProposals for improving the effectiveness of the WHO Governing bodies \nEB154/33 Add.2\nMatters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary\, Programmatic and Financing Governance\nProject plan: implementation of digital solutions for interactions between the Secretariat and Member States on matters related to the governing bodies \nEB154/33 Add.3\nMatters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary\, Programmatic and Financing Governance\nCost recovery mechanisms for voluntary contributions – an update \nEB154/34\nMatters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary\, Programmatic and Financing Governance \nEB154/34 Add.1\nMatters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary\, Programmatic and Financing Governance\nFollow-up to decision WHA69(8) (2016)\, operative paragraph (10) \nEB154/34 Add.2\nMatters emanating from the Agile Member States Task Group on Strengthening WHO’s Budgetary\, Programmatic and Financing Governance\nProposed methodology for costing new initiatives/programmes \nEB154/36\nEngagement with non-State actors\nReport on the implementation of the Framework of Engagement with Non-State Actors \nEB154/37\nEngagement with non-State actors\nNon-State actors in official relations with WHO \nEB154/37 Add.1\nFinancial and administrative implications for the Secretariat of decisions proposed for adoption by the Executive Board \nEB154/38\nNomination and appointment of Regional Directors\nProcess for the election of Regional Directors \nEB154/39\nProvisional agenda of the Seventy-seventh World Health Assembly \nEB154/50\nReport on meetings of expert committees and study groups\nReport by the Director-General \nEB154/50 Add.1\nReport on meetings of expert committees and study groups\nExpert advisory panels and committees and their membership
URL:https://globalbiodefense.com/event/who-executive-board-meeting/
LOCATION:https://www.who.int/about/accountability/governance/executive-board/executive-board-154th-session
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240123
DTEND;VALUE=DATE:20240124
DTSTAMP:20240623T231054Z
CREATED:20240111T194643Z
LAST-MODIFIED:20240623T231054Z
UID:59614-1705968000-1706054399@globalbiodefense.com
SUMMARY:OECD High-Level Policy Forum: Better Policies for More Resilient Health Systems
DESCRIPTION:The Organisation for Economic Co-operation and Development (OECD) will host a Ministerial Meeting on Better Policies for More Resilient Health Systems on 23 January 2024 in Paris\, France and via virtual broadcast. \nAs the world emerges from the biggest public health emergency in more than a century\, it is clear that there are lessons to be learned. The COVID-19 crisis exposed significant weaknesses in health systems\, calling for urgent action to ensure that they more resilient to future shocks. At the same time\, global megatrends such as climate change\, demographic change and increased digitalisation will likely have significant implications for health and healthcare in the years to come. \nIn January 2024\, Health Ministers from OECD and partner countries will come together to discuss the legacy and lessons learned from the COVID-19 crisis\, the health policy challenges that lie ahead\, and the actions needed to address them. The meeting will be Chaired by Belgium\, with Australia\, Chile\, Germany\, Norway and Slovenia serving as Vice-Chairs. \nHighlighted agenda items include: \n\nBolstering public health: Healthy populations for more resilient health systems\nThe future of digital health after COVID-19\nThe future of pharmaceutical policy\n\n“Our health systems have continuously improved over recent decades\, both in terms of investment and outcomes. Many have worked tirelessly to make that happen. Nevertheless\, the COVID-19 pandemic was a sobering reminder: fundamental challenges on issues such as workforce\, prevention and health promotion\, mental health\, inequalities and the supply chain of medical goods continue to put pressure on our health systems\,” notes Frank Vandenbroucke\, Chair of the 2024 OECD Health Ministerial Meeting. “If we want to make our health systems more future-proof\, we must take these challenges seriously – especially in the context of rapid social\, technological and environmental change.” \nThe OECD High-Level Policy Forum on The Future of People-Centred Health Innovation will take place on 22 January 2024\, on the eve of the OECD Health Ministerial Meeting. The Forum will explore policies and priorities for adopting new innovations into health systems and is being organised by the OECD\, in collaboration with the Commonwealth Fund and the Health Foundation and in partnership with Financial Times Live. \nPlease visit the OECD Ministerial Meeting page for more information and to register.
URL:https://globalbiodefense.com/event/oecd-high-level-policy-forum-better-policies-for-more-resilient-health-systems/
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240130T133000
DTEND;TZID=America/New_York:20240130T144500
DTSTAMP:20240623T230714Z
CREATED:20240126T225333Z
LAST-MODIFIED:20240623T230714Z
UID:59713-1706621400-1706625900@globalbiodefense.com
SUMMARY:Kazakhstan’s Actions to Address Nuclear and Biological Risks
DESCRIPTION:The Carnegie Endowment and the Council on Strategic Risks will host a panel on Kazakhstan’s increasingly global role in the changing threat landscape of weapons of mass destruction on 30 January 2024 in Washington DC and by webcast. \nUpon the 1991 collapse of the Soviet Union\, Kazakhstan found itself in possession of the world’s fourth-largest nuclear weapons stockpile and the former union’s most significant biological weapons factory. Kazakhstan’s subsequent decision to return and dismantle these weapons has solidified its position as a leader in nuclear and biological risk reduction. For the last thirty years\, Kazakhstan’s actions have served as a core model for regional and international security. \nThe discussion will feature Kazakhstan’s Ambassador to the United States of America Yerzhan Ashikbayev\, the Honorable Andrew Weber\, and Dr. Toghzan Kassenova. It will be moderated by Shannon Green\, senior fellow at the Council on Strategic Risks. \nPlease visit the Carnegie Endowment’s Kazakhstan’s Actions to Address Nuclear and Biological Risks event page to RSVP.
URL:https://globalbiodefense.com/event/kazakhstans-actions-to-address-nuclear-and-biological-risks/
LOCATION:
END:VEVENT
END:VCALENDAR